Myelodysplastic syndrome patients present with variable cytopenias even though their bone marrows are generally hypercellular. Excessive cytokine-induced apoptosis of hematopoietic cells in the marrows has been proposed as a possible
A. Raza
Advertisement
Articles by A. Raza
Advertisement
Latest Updated Articles
- Encouraging Improvement in Cytopenias of Patients With Myelodysplastic Syndromes With Thalidomide
Published: November 1st 2000 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Lurbinectedin/Atezolizumab Maintenance in ES-SCLC
2
FDA Grants Fast Track Designation to Novel PIK3α Inhibitor in Breast Cancer
3
Tarlatamab Requires Strategic Toxicity Monitoring and Management in ES-SCLC
4
Monitoring Response to Radioligand Therapy in Prostate Cancer
5
